HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever year-end results

This article was originally published in The Rose Sheet

Executive Summary

Dove sales increased more than 33% to over $2.16 bil. (€1=$1.08) in 2002, Chairman Niall FitzGerald reports during Unilever's 1fourth quarter and year-end sales and earnings announcement Feb. 13. Unilever's skin, hair and deodorant business grew by nearly 11% for the year with sales of more than $10.83 bil. Personal care sales for the quarter increased 11.1% to $3.91 bil. and for the year climbed 7.8% to $14.38 bil. at constant 2001 annual average exchange rates, firm states. Division operating profit for the quarter fell 10.2% to $593.7 mil., but increased 9.5% to $2.63 bil...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010981

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel